MyFinsight
Home
Blog
About
Back
Income Statement
Hepion Pharmaceuticals, Inc. (HEPA)
Hepion Pharmaceuticals, Inc. (HEPA)
source: myfinsight.com
Net loss
-$1,248,237
(-19.73%↓ Y/Y)
Interest income
(expense)
$6,243
(28.30%↑ Y/Y)
Loss from operations
-$1,211,491
(30.59%↑ Y/Y)
Change in fair value of
derivative financial...
-$42,989
Total operating
expenses
$1,211,491
(-30.59%↓ Y/Y)
General and
administrative
$1,160,573
(26.22%↑ Y/Y)
Research and development
$50,918
(-87.97%↓ Y/Y)
Back